• Toxoplasma Gondii IgG and IgM, CSF
  • Mycoplasma genitalium, Molecular
  • Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
  • Anti Mullerian Hormone (AMH)
  • 17-Hydroxyprogesterone, Amniotic fluid
  • Hereditary Hemorrhagic Telangiectasia, Gene Mutation Panel
  • Bicarbonate (Carbon Dioxide), Urine
  • Cyclic Citrullinated Peptide (CCP) Antibody, IgG
  • Fluphenazine, Urine
  • Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Fabry Disease (GLA) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Fabry Disease (GLA) Gene Mutation Analysis
Medical Test

Reference Ranges
Access to Fabry Disease (GLA) Gene Mutation Analysis is restricted.
Loading...